MedPath

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Registration Number
NCT00002873
Lead Sponsor
Radiation Therapy Oncology Group
Brief Summary

RATIONALE: Radiation therapy may kill any tumor cells remaining after surgery.

PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating women who have stage I or stage II breast cancer.

Detailed Description

OBJECTIVES: I. Evaluate the technical feasibility and reproducibility, cosmetic results, complication rates, and local cancer control rate experience with brachytherapy used as the sole method of radiotherapy in women with stage I/II breast cancer treated with tylectomy who have histologically assessed negative surgical margins, less than 4 positive axillary nodes, and no extracapsular nodal extension or extensive intraductal component. II. Reduce the total treatment time of breast irradiation from 6 weeks to 4-5 days in these patients.

OUTLINE: Treatment begins no sooner than 4 days and within 6 weeks after definitive surgery. All patients receive brachytherapy to the target volume (as defined by the excision cavity demarcated by post-tylectomy surgical clips plus 2 cm margin) using iridium-192 implants for dose distribution to five planes. Patients may be treated with either high-dose-rate or low-dose-rate brachytherapy at the institution's discretion. Patients are followed at 2 and 6 weeks after treatment, then at 3, 6, 9 and 12 months, then every 4 months for 1 year, every 6 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A maximum of 46 patients will be accrued in each group (high-dose rate vs low-dose rate) over 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (232)

Veterans Affairs Medical Center - Birmingham

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

University of Alabama Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Huntsville Hospital System

πŸ‡ΊπŸ‡Έ

Huntsville, Alabama, United States

Urology Associates - Mobile AL

πŸ‡ΊπŸ‡Έ

Mobile, Alabama, United States

MBCCOP - University of South Alabama

πŸ‡ΊπŸ‡Έ

Mobile, Alabama, United States

Alabama Oncology, LLC

πŸ‡ΊπŸ‡Έ

Montgomery, Alabama, United States

Radiation Oncology Associates of West Alabama

πŸ‡ΊπŸ‡Έ

Tuscallosa, Alabama, United States

Providence Cancer Therapy Center

πŸ‡ΊπŸ‡Έ

Anchorage, Alaska, United States

Arizona Cancer Center

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Providence Saint Joseph Medical Center - Burbank

πŸ‡ΊπŸ‡Έ

Burbank, California, United States

Scroll for more (222 remaining)
Veterans Affairs Medical Center - Birmingham
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.